Search research articles
Contact Us
Filters
Showing results (521-530 of 649) with videos related to
Page
of 65
Sort By:
BMC Cancer
|
November 11, 2025
Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study
Marta Seca, Jacek Gronwald, Tomasz Huzarski, et al.
Commentary (New York, N.Y.)
|
March 1, 1994
Abortion: round 1
Ronald Dworkin, Jonathan Kay, Christopher M Schnaubelt, et al.
Breast Cancer Research and Treatment
|
February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
Susan M Domchek, Tara M Friebel, Judy E Garber, et al.
Gynecologic Oncology
|
August 22, 2024
Incidence of endometrial cancer in BRCA mutation carriers
Joanne Kotsopoulos, Jan Lubinski, Tomasz Huzarski, et al.
Gynecologic Oncology
|
August 10, 2025
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant
Adriana I Apostol, Joanne Kotsopoulos, Jacek Gronwald, et al.
Breast (Edinburgh, Scotland)
|
January 26, 2023
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer
Arlene Chan, Manuel Ruiz-Borrego, Gavin Marx, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2014
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation
Amy P M Finch, Jan Lubinski, Pål Møller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer
Martin Filipits, Torsten O Nielsen, Margaretha Rudas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 2, 2023
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
Ana-Alicia Beltran-Bless, Mark J Clemons, Christian Fesl, et al.
Breast Care (Basel, Switzerland)
|
June 16, 2022
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Simon P Gampenrieder, Magdalena Pircher, Christian Fesl, et al.
Page
of 65
Search research articles
Search
Showing results (521-530 of 649) with videos related to
Sort By:
Page
of 65
BMC Cancer
|
November 11, 2025
Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study
Marta Seca, Jacek Gronwald, Tomasz Huzarski, et al.
Commentary (New York, N.Y.)
|
March 1, 1994
Abortion: round 1
Ronald Dworkin, Jonathan Kay, Christopher M Schnaubelt, et al.
Breast Cancer Research and Treatment
|
February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
Susan M Domchek, Tara M Friebel, Judy E Garber, et al.
Gynecologic Oncology
|
August 22, 2024
Incidence of endometrial cancer in BRCA mutation carriers
Joanne Kotsopoulos, Jan Lubinski, Tomasz Huzarski, et al.
Gynecologic Oncology
|
August 10, 2025
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant
Adriana I Apostol, Joanne Kotsopoulos, Jacek Gronwald, et al.
Breast (Edinburgh, Scotland)
|
January 26, 2023
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer
Arlene Chan, Manuel Ruiz-Borrego, Gavin Marx, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2014
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation
Amy P M Finch, Jan Lubinski, Pål Møller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer
Martin Filipits, Torsten O Nielsen, Margaretha Rudas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 2, 2023
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
Ana-Alicia Beltran-Bless, Mark J Clemons, Christian Fesl, et al.
Breast Care (Basel, Switzerland)
|
June 16, 2022
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Simon P Gampenrieder, Magdalena Pircher, Christian Fesl, et al.
Page
of 65